Direct or indirect Stat3 pathway activation by IL-17A promotes the proliferation and progression of various tumors, whereas IL-17A-mediated adaptive and innate immune responses exert anti-tumor effects [41, 42, 44–47]. This evidence concerns the gene STAT3 and neoplasm.